Gent

• Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel Recruiting
  2023-505530-10-00 6 2022-09-14 Multiple Myeloma
• Prevention of postoperative endoscopic disease recurrence in Crohn’s disease: a multicentric study that compares the systematic start of bio … Recruiting
  2022-500311-39-00 6 2022-09-08 Patients with Crohn's disease undergoing surgery and having at least o
• A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia Recruiting
  2023-503335-18-00 1 2022-07-29 Chronic myeloid leukemia
• A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa (CFA) versus up to three modified natural cycles (MN … Recruiting
  2023-509094-23-00 6 2022-07-15 Subfertility
• A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary biliary cholan … Recruiting
  2023-504660-41-00 4 2022-07-11 Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (PBC
• International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting
  2022-501180-40-00 5 2022-06-17 Ewing Sarcoma
• RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting
  2023-503267-42-00 5 2022-06-10 Patients with a histological diagnosis of mismatch- repair deficient h
• Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting
  2023-508852-21-00 4 2022-06-10 Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer
• Studying Conditioning Regimen In Pediatric Transplantation -AML Recruiting
  2023-505512-37-00 5 2022-06-07 Acute Myeoloid Leukemia
• Brigatinib in pediatric and young adult patients with ALK+ ALCL, IMT or other solid tumors (Briga-PED) Recruiting
  2024-513412-10-00 9 2022-05-11 Anaplastic Large Cell Lymphoma (ALCL)
• A study of MK-7240/PRA023 in patients with Systemic Sclerosis Associated with Interstitial Lung Disease Recruiting
  2023-509743-27-00 4 2022-04-29 Systemic sclerosis associated with interstitial lung disease
• Metastasis-directed therapy, whether or not in combination with hormone therapy, in patients with prostate cancer recurrence after initial t … Recruiting
  2022-502373-42-00 5 2022-04-25 Oligorecurrent hormone-sensitive prostate cancer patients
• Phase 1/2 study of IMC-M113V in virologically suppressed chronic HIV infection Recruiting
  2024-513938-38-00 7 2022-04-06 Chronic HIV infection
• A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer … Recruiting
  2024-512089-32-00 3 2022-03-28 Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
• “NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC … Recruiting
  2024-516336-97-00 4 2022-02-21 METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
• Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i … Recruiting
  2023-504166-37-00 4 2022-02-01 Advanced ovarian, tubal or peritoneal cancer.
• A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituxim … Recruiting
  2024-510690-16-00 5 2022-01-31 Relapsed/refractory follicular lymphoma
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting
  2023-505438-85-00 5 2022-01-12 Acute myocardial infarction (AMI)
• A study to evaluate the Safety, Pharmacokinetics, and Activity of Subcutaneous Cevostamab (BFCR4350A) in Patients with Relapsed or Refractor … Recruiting
  2023-503404-89-00 3 2021-12-08 Relapsed or Refractory Multiple Myeloma R/R MM
• Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis Recruiting
  2023-504152-97-00 5 2021-11-26 Generalized Myasthenia Gravis
• SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting
  2024-510578-25-00 5 2021-11-05 Histologically proven high-risk medulloblastoma, with any of the curre
• HARBOR: Study of BLU-263 for Indolent Systemic Mastocytosis Recruiting
  2024-516728-32-00 10 2021-10-29 Indolent Systemic Mastocytosis and SSM
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Subcutaneous Glofitamab following Obinutuz … Recruiting
  2023-507728-22-00 3 2021-06-25 Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
• A Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of RO7121932 following Intravenous a … Recruiting
  2023-509357-31-00 1 2021-06-01 Multiple Sclerosis (MS)

Showing 385–408 of 904 trials